Eliminating Lymphatic Filariasis. Success in science, intervention and beyond..
|
|
- Earl Edwards
- 5 years ago
- Views:
Transcription
1 Eliminating Lymphatic Filariasis Success in science, intervention and beyond.. Eric A. Ottesen, M.D. 30 January 2007
2 LF Disease
3 LF Disease
4 Adult parasites (W. bancrofti) in scrotal lymphatic Dreyer & Noroes
5 LF Disease Other clinical manifestations Filarial fevers Tropical Pulmonary Eosinophilia Chyluria Hematuria/Proteinuria others less well defined
6 LF Infection Asymptomatic microfilaremia Adult Worms L4 Human Mf L3 Mosquito L2
7 Why do we focus on LF now? Partly, it s because of LF s importance LF imposes a health burden affecting 120 million people 40 million with overt disease 80 million with hidden infection and disease 1.1 billion people at risk of infection 83 endemic countries throughout the tropics/sub-tropics leading cause of disability, stigma, economic loss
8 LF Endemic Countries & Territories Fourth GAELF, Fiji Mar 2006
9 Why do we focus on LF now? Partly, it s because of LF s importance LF imposes a health burden affecting 120 million people 40 million with overt disease 80 million with hidden infection and disease 1.1 billion people at risk of infection 83 endemic countries throughout the tropics/sub-tropics leading cause of disability, stigma, economic loss Especially, because we can do something about it!
10 Why do we focus on LF now? It a really good science story? Research Understanding Tools Strategy Public Health Implementation bench bedside community
11 Towards Public Health Implementation? Research Understanding Tools Strategy Public Health Implementation 1 st step: to define a clear goal
12 Global Program to Eliminate LF (GPELF) Operational Goals 1) To interrupt LF transmission 2) To alleviate and prevent the suffering of those already affected
13 Global Program to Eliminate LF (GPELF) Operational Goals 1) To interrupt LF transmission 2) To alleviate and prevent the suffering of those already affected
14 New understandings: pathogenesis of lymphedema/elephantiasis 1) Recognition that LF is an infection acquired in childhood % % Diagnosis by Antigen 10 6% 0 2 years 4 years age of children in cohort Haiti; Antigen Lammie et al
15 New understandings: pathogenesis of lymphedema/elephantiasis 2) Recognition of sub-clinical lymphatic damage Lymphoscintigraphy (legs) Ultrasound (scrotal lymphatic) normal LF (aysmptomatic mf+)
16 New understandings: pathogenesis of lymphedema/elephantiasis 3) Identifying the etiology and importance of filarial fevers (acute inflammatory episodes) ADL DLA
17 New understandings: pathogenesis of lymphedema/elephantiasis 4) Recognizing that bacterial superinfection was the principal determinant of disease progression Entry Lesions
18 Hygiene New understandings: management of lymphedema/elephantiasis Preventing bacterial infections is the primary goal of managing patients with lymphedema Treatment and prevention of skin lesions Exercise Elevation Shoes Bandages
19 LF genital disease: pathogenesis & management Pathogenesis: lymphatic distortion +/- bacterial infection Management: for hydrocele, surgery is cure for genital lymphedema/elephantiasis, hygiene
20 Global Program to Eliminate LF (GPELF) Operational Goals 1) To interrupt LF transmission 2) To alleviate and prevent the suffering of those already affected
21 For the LF program, the goal is elimination What does elimination mean? The incidence of infection must become zero Transmission must be interrupted What does it take to achieve elimination? Effective interventions Effective diagnostics
22 LF Infection Asymptomatic microfilaremia Adult Worms L4 Human Mf L3 Mosquito L2
23 Effective tools: for intervention The anti-filarial drugs DEC ALB Diethylcarbamazine (DEC) Ivermectin (IVR) L4 Adult Worms Human Mf DEC IVR Albendazole (ALB) L3 Mosquito L2
24 Effectiveness of Single Doses of Antifilarial Drugs 100 % Pre-treatment (mf/ml) DEC Ivermectin Albendazole Months Post Treatment (Meta-analysis 8-20 studies each)
25 ALBENDAZOLE, IVERMECTIN & DEC 2-Drug Regimens Microfilaraemia (% Pre-Rx) Blood Microfilaria Levels (W. bancrofti) ALB+IVER ALB+DEC Months Post Treatment Single-Dose Treatment Ismail et al. 96
26 What makes a disease eliminatable? Effective intervention tools Effective diagnostic tools
27 New diagnostic: antigen-detection test (W.bancrofti) High sensitivity (>95%) High specificity (99%) Uses finger-prick blood Rapid (1-10 minutes) Positive night and day Field-useable Commercially available (cost: $2.50/test for public health programs)
28 LF does have effective tools For intervention For diagnosis For managing LF disease
29 The challenge for all our programs? Research Understanding Tools Strategy Public Health Implementation
30 Creating a strategy for LF elimination: Previously Diagnose Treat Individual Individual
31 Creating a strategy for LF elimination: major paradigm shift Previously Now Diagnose Individual Population Treat Individual Population
32 Creating a strategy to eliminate LF: Interrupt transmission: 1 st major paradigm shift Identify all LF-endemic areas Treat entire at risk populations 2-drug, single-dose regimens once-yearly x 4-6 years by mass drug administration (MDA)
33 Creating a strategy to eliminate LF: Interrupt transmission: 1 st major paradigm shift Identify all LF-endemic areas Treat entire at risk populations 2-drug, single-dose regimens once-yearly x 4-6 years by mass drug administration (MDA) Alleviate suffering / Prevent disease Introduce new principles of hygiene and patient care to prevent and manage LF disease
34 The challenge for all our programs Phase l? Research Understanding Tools Strategy Phase-2 Phase l Public Health Implementation
35 The challenge for all our programs Phase l? Research Understanding Tools Strategy Phase-2 Phase l Public Health Implementation
36 Public Health Implementation Must speak a new language? Research Understanding Tools Strategy antigens primers receptors transduction pharmacokinetics IL-1, IL-4, IL-13 genomics proteomics Public Health Implementation partnerships collaborations alliances business plans cost-effectiveness health systems equity MDGs
37 Public Health Implementation Absolute requirements: Political commitment Resources Determination to work together (as partners)
38 LF Elimination: - scientific political commitment- 1993: International Task Force on Disease Eradication The 2 essential criteria for eradicability were met Other attributes (biological) favored eradicability LF elimination has been successful before! LF: one of 6 diseases eradicable or potentially eradicable
39 LF Elimination: - governmental political commitment- Ministries of Health individual commitment by MOH to establish national LF elimination programmes collective commitment : WHA Resolution 97 Urges Member States...to strengthen activities toward eliminating lymphatic filariasis as a public health problem... Requests the Director-General...to mobilize support for global and national elimination activities.
40 Public Health Implementation Absolute requirements: Political commitment Resources Determination to work together (as partners)
41 LF Elimination: -early donations of resources- To donate all albendazole required for LF elimination; to support selected research and program activities Merck and Co. Inc Whitehouse Station, NJ, USA, UK Arab Fund Japan To expand Mectizan Donation Program to provide ivermectin for LF treatment where onchocerciasis co-exists Long-term support of programme development and intervention in the countries and globally, through WHO and the LF support centres To support activities toward elimination of LF from all Arab Fund member countries To support programme training activities and efforts to eliminate LF from the Pacific island nations (PacELF)
42 The challenge for all our programs Phase l? Research Understanding Tools Strategy Phase-2 Phase l Public Health Implementation
43 What s the most important thing in real estate? Location Location Location
44 What s the most important thing in global health? Partnership Partnership Partnership
45 Public Health Implementation Absolute requirements: Political commitment Resources Determination to work together (as partners)
46 Global Alliance Partnership Strategic Plan for the Partners Targets Milestones Roles of partners
47 Global Alliance To Eliminate Lymphatic Filariasis WHO Arab Fund for Economic and Social Development Japan Liverpool School of Tropical Medicine Bill and Melinda Gates Foundation Unicef Health & Development International World Bank CDC US Centers for Disease Control and Prevention
48 Success requires partnership Public-sector partners Ministries of Health Overseas Development Agencies Private-sector partners Pharmaceutical companies Foundations NGOs, technical agencies, academia, others People partners people-power in the programmes in the communities
49 Success requires partnership Phase l? Research Understanding Tools Strategy Phase-2 Phase l Public Health Implementation
50 LF Elimination The Global Program(me) ( )
51 Global Program to Eliminate LF (GPELF) Operational Goals 1) To interrupt LF transmission through MDAs 2) To alleviate and prevent the suffering of those already affected
52 Mass Drug Administration (MDA)
53 Countries with LF Elimination Programs (2006) 15 Pacific Island Countries Countries with active LF elimination programs Countries endemic for LF which have only incipient or not yet active elimination i programs Countries with active LF elimination programs and specific demonstration projects funded by the Gates Foundation
54 Global Programme Progress Number of treatments (millions) Number of country programmes Treatments administered (both single and dual drug) Country programmes
55 MDA Reduces Microfilaria Prevalence Egypt Vanuatu K. Bahary K. Qebly K. Tahoria Tahoria Sola Mos ina Port R. S. River Prevalence (%) Prevalence (%) Sakau Wanur Orap Unmet 0 Pre-Rx Year 1 Year 2 Year 3 0 Pre-RX Year 1 Year 2 Year 3 Haiti Papua New Guinea Leogane Mapou Masson Barrier Jeudi Site 1 Site 2 Site 3 Site 4 Prevalence (%) Pre-Rx Year 1 Year 2 Year 3 Prevalence (%) Pre-RX Year 1 Year 2 Year 3 Year 4
56 Impact of MDA on Microfilaria Clearance at Sentinel Sites After 2 or 3 MDAs 13% 43% Total clearance 50%-99% clearance <50% clearance 44%
57 The Global Programme to Eliminate Lymphatic Filariasis on track and doing well... but are there still problems/challenges?
58 Are there still problems/challenges for LF? Very definitely!? Research Understanding Tools Strategy Public Health Implementation
59 Are there still problems/challenges for LF? Very definitely! Understanding? Research Public Health Tools Implementation Strategy WHO/TDR Scientific Working Group May 2005 Gates Foundation Grant to GAELF
60 Facing the facts.. Our programmes in many places, are now starving for funds are extremely well organized and well run are highly popular with communities are successful in achieving their targets are ridiculously inexpensive for the benefit attained could be successfully and fully implemented if funds were available LF has proven to be a major challenge to market
61 So what should be done? It s time for a 2 nd major paradigm shift
62 What s the most important thing in global health? Partnership Partnership Partnership
63 Programme success 2 nd major paradigm shift Strategy to ensure LF elimination: Previously Now Implementation LF alone with NTDs Advocacy/fundraising LF alone with NTDs
64 Package of Neglected Tropical Diseases ( Targets of Opportunity / Rapid impact Diseases ) Lymphatic filariasis (LF) Onchocerciasis Schistosomiasis Soil-transmitted helminthiasis (STH) Trachoma
65 The devil is in the detail.. What could/should be integrated? MDA Medications and their delivery IEC/Social mobilization Logistics Monitoring & Evaluation Morbidity management Fundraising & Advocacy
66 Promise of the Future for NTDs Success in implementation: from exploiting the synergies among public health initiatives sharing similar strategies Lymphatic Filariasis GPELF Onchocerciasis APOC Schistosomiasis - SCI Soil Transmitted Helminths PPC Trachoma ITI Micronutrient Initiative Success in resource mobilization: from attractiveness of integrated management of packages of programmes targeting important but otherwise-neglected diseases Arguably the best buy in global health today!
67 Comparative Treatment Costs (Range) HIV/AIDS Ref: Clinton Foundation, Bertozzi, etal 2004, Bautista 2003 TB Ref: Global TB Control 2005 Malaria Ref: Chmia, 2003; Molyneux et al 2005 NTD Package Ref: Brady et al Cost per patient treatment per year (US dollars)
68 Global Disease Burden (DALYs) DALYs (in millions) Ischemic heart disease 58.6 Diarrheal diseases 62.0 Unipolar depression 67.3 HIV / AIDS 84.5 Neglected tropical diseases 56.6 Lower Respiratory Infections 91.4 Cerebrovascular diseases 49.2 Malaria 46.5 Road traffic accidents 38.7 Tuberculosis 34.7
69 Integrating Neglected Tropical Disease Control
70 Global Network for Neglected Tropical Diseases Schistosomiasis Control Initiative International Trachoma Initiative Helen Keller International Liverpool School - GAELF Human Hookworm Vaccine Initiative Earth Institute at Columbia Univ. Task Force for Child Survival Lymphatic Filariasis Support Center Mebendazole Donation Intiative Mectizan Donation Program
71 New NTD Control Projects The Global Network for Neglected Tropical Disease Control 8 / 56 Countries Geneva Global Burundi Rwanda Exxon Mobil Equatorial Guinea USAID Burkina Faso Ghana Mali Niger Uganda
72 The Buzz on NTDs The world is now paying attention to these [neglected] It Comprehensive, quickly We learned diseases became that and Africa-wide making clear this that integration progress this control story is in of unprecedented is a malaria not long just process, and about NTDs ways, the but it is staggering together worth with ambitious would doing, numbers probably and goals, of we the are cost excellent world s learning no more citizens interventions, by than doing overwhelmed $3 that billion and process. a growing year, by HIV, or just evidence AIDS, Dominique TB, two days of and multiple of Kyelem, malaria. Pentagon benefits Burkina And it s spending. for Faso not health. just If each Ministry The the story of attention the of about billion Health, to one people Lymphatic billion long-neglected people in the rich Filariasis who world diseases are devoted Control afflicted is a the positive Program with disabling, equivalent sign that oftentimes of one health $3 is a stigmatizing, responsibility neglected shared tropical by the diseases, international such community. as human hookworm coffee a year infection to the and cause, elephantiasis several million it s children all about every the faces -Dr. Margaret Chan, Director-General of the World year Health would of dying be children Organization spared of and death sick and mothers debility, who and haunt world those who have seen them...what struck me, and what I think struck would us be all that spared the these grave challenges risks when are disease all interconnected. and despair - run Clinton unchecked. Global A Initiative, new Global Closing Network Remarks for Neglected Tropical Disease Control is helping make this opportunity a reality. - Jeffrey Sachs, Director of the Earth Institute, Scientific American January 2007
73 World s first peer-reviewed, open-access journal devoted to the NTDs Launch supported by Bill and Melinda Gates Foundation Papers on pathology, epidemiology, treatment, control, prevention Magazine section devoted to policy and advocacy International editorial board half of the Associate Editors are from endemic countries Accepting submissions in early 2007 It is expected that the journal will be both catalytic and transformative in promoting science, policy, and advocacy for these diseases of the poor. Peter Hotez, Editor-in-Chief
74 Successes, Challenges, Way Forward Must recognize that we have extraordinary opportunities to make enormous impact on the health and economies of the developing world, at very low cost. we simply cannot do it. alone Success will come from exerting flexibility, changing old habits, creating new partnerships new coalitions of coalitions No longer speak solely of LF and the Global Programme to eliminate it -- now it s LF and Beyond the NTDs & other Global Health challenges
75 maybe this will be the new NTD face of LFelimination, schisto control,.
76
77 Costs for Treating 5 Neglected Diseases at 2006 Target Levels in Sub Saharan Africa Cost per person - treat each disease separately $1.07 Total cost - treat each disease separately $109 million Cost per person - treat packaged NTDs $0.57 Total cost - treat packaged NTDs $58 million
78 Outcomes Projected from Integrated Treatment of 5 NTDs in SSA (at 2006 Levels) 10.5 million children protected from STH 14.7 million adults protected from STH 5 million cases of skin disease and itching prevented 570,000 pregnant women protected from anemia 100,000 people protected from severe kidney or bladder disease 65,000 cases of hydrocele prevented 28,000 cases of lymphedema prevented 25,000 cases of blindness prevented 5,000 people protected from life-threatening liver disease
The Schistosomiasis Control Initiative (SCI) Professor Alan Fenwick
The Schistosomiasis Control Initiative (SCI) Professor Alan Fenwick Department of Infectious Disease Epidemiology School of Public Health Imperial College (St Mary s campus) Established in 2002 SCI assists
More informationGABON. Neglected tropical disease treatment report profile for mass treatment of NTDs
GABON Neglected tropical disease treatment report 2017 1 2017 profile for mass treatment of NTDs NEGLECTED TROPICAL DISEASES Neglected tropical diseases (NTDs) are a group of preventable and treatable
More informationSchistosomiasis and Neglected Tropical Diseases Control
Schistosomiasis and Neglected Tropical Diseases Control S C I Children Boys 7 years Wanseko P/S Vector Control Division * Ministry of Health * Tel: 41 251 927 * Fax: 41 346 885 * Professor Joanne P. Webster
More informationmore than 6 million people at risk of contracting one or more diseases
NTDs in Togo Neglected tropical diseases (NTDs) affect all 40 districts in Togo, putting more than 6 million people at risk of contracting one or more diseases. NTDs are debilitating and disproportionately
More information25 million Ghanaians are at risk of contracting one or more diseases
NTDs in Ghana Neglected tropical diseases (NTDs) affect all 10 regions of Ghana, and an estimated 25 million Ghanaians are at risk of contracting one or more diseases. NTDs are debilitating and disproportionately
More informationMASS TREATMENT COVERAGE FOR NTDS Togo and neglected tropical diseases
MASS TREATMENT COVERAGE FOR NTDS - 2016 Togo and neglected tropical diseases Neglected tropical diseases Neglected tropical diseases are a group of preventable and treatable diseases that affect 1.5 billion
More informationMASS TREATMENT COVERAGE FOR NTDS Democratic Republic of the Congo and neglected tropical diseases
MASS TREATMENT COVERAGE FOR NTDS - 2016 Democratic Republic of the Congo and neglected tropical diseases Neglected tropical diseases Neglected tropical diseases are a group of preventable and treatable
More informationMASS TREATMENT COVERAGE FOR NTDS Somalia and neglected tropical diseases
MASS TREATMENT COVERAGE FOR NTDS - 2016 Somalia and neglected tropical diseases Neglected tropical diseases Neglected tropical diseases are a group of preventable and treatable diseases that affect 1.5
More informationSummary of the Twelfth Meeting of the ITFDE (II) May 6, 2008
Summary of the Twelfth Meeting of the ITFDE (II) May 6, 2008 The Twelfth Meeting of the International Task Force for Disease Eradication (ITFDE) was convened at The Carter Center from 8:30am to 4:00pm
More informationCommunity Directed Intervention for Onchocerciasis Control and Public Health Interventions
Community Directed Intervention for Onchocerciasis Control and Public Health Interventions USF College of Public Health Tampa Florida, April 9, 2010 Dr. Boakye Boatin 11 University of Medical Sciences
More informationThe Neglected Tropical Diseases of Guinea, Liberia, Sierra Leone
The Neglected Tropical Diseases of Guinea, Liberia, Sierra Leone Peter Hotez MD PhD @PeterHotez The Millennium Development Goals 1. Eradicate extreme poverty and hunger. 2. Achieve universal primary education.
More informationIntegrating NTD drug packages into a Child Nutrition Campaign
Integrating NTD drug packages into a Child Nutrition Campaign Achille Kabore, MD MPH Senior Technical Advisor NTD Control Program RTI International Washington, DC May 4 th 2011 Overview of the Neglected
More informationPartners. hygiene. progress. END in Africa & Burkina Faso. community. support health. e e e e e e e e e e e e e e e. endinafrica.
thrive control awareness care hygiene prevention assessment treatment access progress Partners on NTDs END in Africa & Burkina Faso community capacity-building support health e e e e e e e e e e e e e
More informationThe Regional Strategic Plan for Elimination of Lymphatic Filariasis
Lymphatic filariasis is the second leading cause of disability worldwide. The WHO South-East Asia Region accounts for about 65% of the global population at risk. Strategic plans for 2007 2010 for lymphatic
More informationThank you for the opportunity to submit testimony on the Fiscal Year (FY) 2014 State
Drugs for Neglected Diseases initiative, North America Jennifer Katz, Policy Director March 2013 Testimony to the Subcommittee on State and Foreign Operations, Committee on Appropriations United States
More informationNeglected Tropical Diseases
Neglected Tropical Diseases 26-27 Achievements 28 Challenges Dr Lorenzo Savioli Director The Neglected Tropical Disease extended family Lymphatic filariasis Onchocerciasis Schistosomiasis Soil-transmitted
More informationAnnual Highlights. The accomplishments of the Mectizan Donation Program in its 29th year
2015 Annual Highlights The accomplishments of the Mectizan Donation Program in its 29th year 10 Years Building Research and Laboratory Capacity in Cameroon: The Center for Research on Filariasis and Other
More informationPartnering to tackle Neglected Tropical Diseases
Partnering to tackle Neglected Tropical Diseases 2013 IEEE Global Humanitarian Technology Conference Tala de los Santos Diagnostics Group Leader 21 October 2013 NEGLECTED TROPICAL DISEASES The most important
More informationNeglected Tropical & Zoonotic Diseases and their Impact on Women s and Children s Health
Neglected Tropical & Zoonotic Diseases and their Impact on Women s and Children s Health Marian C. McDonald DrPH, MPH, MA Associate Director of Health Disparities National Center for Emerging and Zoonotic
More informationSEA-CD-275. Frequently asked questions
SEA-CD-275 Frequently asked questions on LYMPHATIC FILARIASIS (ELEPHANTIASIS) World Health Organization 2013 All rights reserved. Requests for publications, or for permission to reproduce or translate
More informationTimeline of Carter Center Health Programs, 1982 to 2009
1982 1985 1986 1991 1992 Timeline of Carter Center Health Programs, 1982 to 2009 is established by former U.S. President Jimmy Carter and his wife, Rosalynn, in partnership with Emory University. Groundbreaking
More informationNTDs Slated for Elimination and Eradication
NTDs Slated for Elimination and Eradication Institute of Medicine Forum on Microbial Threats The Causes and Impacts of Neglected Tropical and Zoonotic Diseases September 21-22, 2010 Washington, DC Donald
More informationSeventh meeting of the Global Alliance to Eliminate Lymphatic Filariasis: reaching the vision by scaling up, scaling down, and reaching out
Brady Parasites & Vectors 2014, 7:46 MEETING REPORT Open Access Seventh meeting of the Global Alliance to Eliminate Lymphatic Filariasis: reaching the vision by scaling up, scaling down, and reaching out
More informationHealth and Global Policy Institute Breakfast Briefing 29 November 2011
Health and Global Policy Institute Breakfast Briefing 29 November 2011 Judith Watt Strategic t Consultant t to NCD Alliance www.ncdalliance.org Good morning... I will address three points Why tackling
More informationDisease Control Priorities. Presentation Sub-title Seventh International Rotavirus Symposium Lisbon June 12, 2006
Disease Control Priorities and Rotavirus Presentation Vaccines Title Presentation Sub-title Seventh International Rotavirus Symposium Lisbon June 12, 2006 1 What is the DCPP? DCPP is an alliance of organizations
More informationModule 2. NTD Strategies
Overview LF and Trachoma MMDP Spectrum of morbidity associated with LF and its impact Cause and management of lymphoedema caused by LF Cause and management of hydrocele caused by LF How LF morbidity management
More informationIN THIS ISSUE: LYMPHATIC FILARIASIS: ELIMINATING ONE OF HUMANITY S MOST DEVASTATING DISEASES
ACTION AGAINST WORMS JULY 2010 ISSUE 14 Lymphatic filariasis patient, Debaraj Behera, in Dhalapathar, Orissa, India, 2009. IN THIS ISSUE: Lymphatic filariasis: eliminating one of humanity s most devastating
More informationPolicy and technical topics: Selected neglected tropical diseases targeted for elimination: kala-azar, leprosy, yaws, filariasis and schistosomiasis
REGIONAL COMMITTEE Provisional Agenda item 8.3 Sixty-eighth Session SEA/RC68/12 Dili, Timor-Leste 7 11 September 2015 21 July 2015 Policy and technical topics: Selected neglected tropical diseases targeted
More informationBriefing Document for Neglected Tropical Diseases
Briefing Document for Neglected Tropical Diseases If we are serious about universal health coverage, we must intensify our efforts and our commitment to control, eliminate or eradicate these diseases by
More informationTUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.
30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE
More informationThis summary outlines the burden of targeted diseases and program implementation outcomes in Rwanda. AFRICAN REGION LDC LIC
Rwanda The control of neglected tropical diseases represents a major challenge to those providing healthcare services in the endemic countries. The purpose of this country profile is to provide public
More informationSchistosomiasis Alan Fenwick
Professor Department of Infectious Disease Epidemiology, Faculty of Medicine Imperial College, London 1 (Bilharzia) is caused by trematode worms which inhabit the blood vessels around the bladder or in
More informationSummary of the Eighth Meeting of the ITFDE (II) October 4, 2005
Summary of the Eighth Meeting of the ITFDE (II) October 4, 2005 The Eighth Meeting of the International Task Force for Disease Eradication (ITFDE) was convened at The Carter Center from 9:00am to 4:00pm
More informationNEGLECTED TROPICAL DISEASES AND ANEMIA - WHAT DO WE KNOW
NEGLECTED TROPICAL DISEASES AND ANEMIA - WHAT DO WE KNOW 18 October, 2016- Accelerated Reduction Efforts on Anaemia COP Webinar Yaobi Zhang Contents 1. What are the neglected tropical diseases (NTDs)?
More informationThe development and introduction of vaccines for the developing world
The development and introduction of vaccines for the developing world Bill and Melinda Gates Foundation Founded January 2000 $ 24 B in assets Has awarded $ 5.95 B in grants Foundation Programs Global Health
More informationJaderson Lima, MD On behalf of François Bompart, MD
Challenges and Successes of the FACT Project through Innovative Partnerships for the Development of Artesunate Combination Therapies for Malaria 5º. ENIFarMed São Paulo Brazil August 2011 Public-private
More informationETHIOPIA SCHISTOSOMIASIS AND SOIL-TRANSMITTED HELMINTHES CONTROL PROGRAMME: PROGRESS AND PROSPECTS ABSTRACT INTRODUCTION
Nebiyu Negussu, Birhan Mengistu, Biruck Kebede, Kebede Deribe, Ephrem Ejigu, Gemechu Tadesse, Kalkidan Mekete, Mesfin Sileshi, Ethiop Med J, 2017, Vol. 55, Supp. 1 ETHIOPIA SCHISTOSOMIASIS AND SOIL-TRANSMITTED
More informationFighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010
Fighting Harder and Smarter Against Malaria Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010 Outline Burden of malaria Global support for rolling back malaria
More informationPROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS
29 June 2009 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, 31 August 4 September 2009 Provisional agenda item 9.2 PROGRESS REPORT ON CHILD SURVIVAL: A
More informationTMH TO THE GATES FOUNDATION: HOW SMALL TOWN ROOTS LEAD TO BIG TIME SOLUTIONS FOR TROPICAL DISEASE
TMH TO THE GATES FOUNDATION: HOW SMALL TOWN ROOTS LEAD TO BIG TIME SOLUTIONS FOR TROPICAL DISEASE Julie Jacobson, MD DTMH Neglected Infectious Diseases Bill & Melinda Gates Foundation Overview A bit about
More informationThis summary outlines the burden of targeted diseases and program implementation outcomes in Guinea-Bissau. AFRICAN REGION LIC
-Bissau The control of neglected tropical diseases represents a major challenge to those providing healthcare services in the endemic countries. The purpose of this country profile is to provide public
More informationSUMMARY OF THE THIRD MEETING OF THE ITFDE(II) October 18, 2002
SUMMARY OF THE THIRD MEETING OF THE ITFDE(II) October 18, 2002 This meeting of the International Task Force for Disease Eradication (ITFDE) was convened at The Carter Center from 9:00am to 4:00pm on October
More informationResolutions of the 50 th East, Central and Southern African Health Ministers Conference
50 th ECSA HMC East, Central and Southern African Health Community ECSA-HC February 2010 Resolutions of the 50 th East, Central and Southern African Health Ministers Conference Serena Hotel, Kampala Uganda
More informationThis summary outlines the burden of targeted diseases and program implementation outcomes in Mali. AFRICAN REGION LDC LIC
Mali The control of neglected tropical diseases represents a major challenge to those providing healthcare services in the endemic countries. The purpose of this country profile is to provide public health
More informationUNAIDS 2013 AIDS by the numbers
UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since
More informationThis summary outlines the burden of targeted diseases and program implementation outcomes in the Niger. AFRICAN REGION LDC LIC
Niger (the) The control of neglected tropical diseases represents a major challenge to those providing healthcare services in the endemic countries. The purpose of this country profile is to provide public
More informationThis summary outlines the burden of targeted diseases and program implementation outcomes in Angola. AFRICAN REGION LDC LMI
Angola The control of neglected tropical diseases represents a major challenge to those providing healthcare services in the endemic countries. The purpose of this country profile is to provide public
More informationo A solid evidence base
School-Based Deworming An Education Policy Priority o A solid evidence base o A simple, safe and cost-effective solution Lesley Drake University of California, Berkeley, April 2010 400 000 000 children
More information2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges
Outline of what it will take Tuberculosis Elimination 25: Global and Local Challenges Anne Fanning, MD November 9, 211 21 global TB trends, goals How DOTS happens at country level - an exercise New strategies
More informationEx post evaluation Tanzania
Ex post evaluation Tanzania Sector: Health, family planning, HIV/AIDS (12250) Project: Promotion of national vaccination programme in cooperation with GAVI Alliance, Phase I and II (BMZ no. 2011 66 586
More informationThis summary outlines the burden of targeted diseases and program implementation outcomes in Gabon. AFRICAN REGION
Gabon The control of neglected tropical diseases represents a major challenge to those providing healthcare services in the endemic countries. The purpose of this country profile is to provide public health
More informationChallenges and Opportunities for Responding to HIV/AIDS in LDCs. Mazuwa Banda Department of HIV/AIDS World Health Organization
Challenges and Opportunities for Responding to HIV/AIDS in LDCs Mazuwa Banda Department of HIV/AIDS World Health Organization Outline of Presentation Global HIV/AIDS epidemic HIV/AIDS and LDCs Challenges
More informationWestern Pacific Region Neglected Tropical Diseases News
Western Pacific Region Neglected Tropical Diseases News 2015 Issue 1 Welcome to Western Pacific NTD News! This newsletter, to be published quarterly by the WHO Regional Office for the Western Pacific,
More informationTB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director
TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition
More informationWHO Consultation on universal access to core malaria interventions in high burden countries: main conclusions and recommendations
WHO Consultation on universal access to core malaria interventions in high burden countries: main conclusions and recommendations 12-15 February 2018 Salle XI, ILO Building, Geneva, Switzerland Country
More information~Health and Development Initiative~
~Health and Development Initiative~ Global Issues Division International Cooperation Bureau Ministry of Foreign Affairs, Japan March 2007 More than 10 million children
More informationBackground. Proposed to develop a framework for action. Address by Foreign Minister Koumura
July 2008 Ministry of Foreign Affairs of Japan Background Address by Foreign Minister Koumura Global Health and Japan s Foreign Policy From Okinawa to Toyako (25 November 2007) Special Address by Prime
More informationGlobal Malaria Initiative
Global Malaria Initiative Appeal No. MAA00031 21/04/2009 This report covers the period 01/01/2008 to 31/12/2008. Volunteers from the Madagascar Red Cross participate in malaria behaviour change communication
More informationDECISION MAKING FOR NCDs IN KENYA. Dr. Francis Kimani Director of Medical Services Ministry of Medical Services, Government of Kenya
DECISION MAKING FOR NCDs IN KENYA Dr. Francis Kimani Director of Medical Services Ministry of Medical Services, Government of Kenya AFRICA Kenya GEOGRAPHY OF KENYA ECONOMIC INDICATORS Population of about
More informationANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA
4 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 16 PROGRESS REPORT ON POLIOMYELITIS ERADICATION
More information2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030
S T A T E M E N T 2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030 World leaders commit to reach three goals and 20 new Fast-Track Targets
More informationMODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit
MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative
More informationITALY Mobilizing support for the Global Fund to Fight AIDS, Tuberculosis, and Malaria
ITALY 3.1. HEALTH FINANCING AND STRENGTHENING HEALTH SYSTEMS 3.1.1 We will continue our efforts towards the goal of providing at least a projected US$ 60 billion to fight infectious diseases and improve
More informationThe outlook for hundreds of thousands adolescents is bleak.
Adolescents & AIDS Dr. Chewe Luo Chief HIV/AIDS, UNICEF Associate Director, Programmes Division 28/11/17 Professor Father Micheal Kelly Annual Lecture on HIV/AIDS Dublin, Ireland The outlook for hundreds
More informationG20 CALL TO ACTION. Introduction. Why the G20 should address global health
G20 CALL TO ACTION Introduction This November, the Group of 20 (G20) will gather in Brisbane, Australia to discuss ways to stimulate economic growth among the world s vulnerable populations. The G20 Summit
More informationPROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA
5 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 17.1 PROGRESS REPORT ON THE ROAD MAP FOR
More informationThis summary outlines the burden of targeted diseases and program implementation outcomes in Côte d Ivoire. AFRICAN REGION LIC
Côte d Ivoire The control of neglected tropical diseases represents a major challenge to those providing healthcare services in the endemic countries. The purpose of this country profile is to provide
More informationDOWNLOAD OR READ : TROPICAL INFECTIOUS DISEASES SECOND EDITION PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : TROPICAL INFECTIOUS DISEASES SECOND EDITION PDF EBOOK EPUB MOBI Page 1 Page 2 tropical infectious diseases second edition tropical infectious diseases second pdf tropical infectious
More informationPublic-private partnerships: an overview
Transactions of the Royal Society of Tropical Medicine and Hygiene (2005) 99S, S1 S8 Public-private partnerships: an overview Roy Widdus Initiative on Public-Private Partnerships for Health (IPPPH), Global
More informationustainable Development Goals
26 April 2018 ustainable Development Goals Peter Okoth enya Pediatric Association Conference 3-27 April 2018 ombasa, Kenya UNICEF/UNI197921/Schermbrucker MDG Global Achievements: The Benefits of Global
More informationThe Challenge of Malaria
The Challenge of Malaria Prof. Awa-Marie Coll-Seck Executive Director of RBM Partnership Donors Forum (co-organized by MMV & CRESIB) Barcelona, 15 March 2010 A DECADE OF ROLLING BACK MALARIA: WHERE ARE
More informationCopenhagen, Denmark, September August Malaria
Regional Committee for Europe 64th session EUR/RC64/Inf.Doc./5 Copenhagen, Denmark, 15 18 September 2014 21 August 2014 140602 Provisional agenda item 3 ORIGINAL: ENGLISH Malaria Following the support
More informationThis summary outlines the burden of targeted diseases and program implementation outcomes in Malawi. AFRICAN REGION LDC LIC
Malawi The control of neglected tropical diseases represents a major challenge to those providing healthcare services in the endemic countries. The purpose of this country profile is to provide public
More informationThis summary outlines the burden of targeted diseases and program implementation outcomes in Ethiopia. AFRICAN REGION LIC
Ethiopia 21 The control of neglected tropical diseases represents a major challenge to those providing healthcare services in the endemic countries. The purpose of this country profile is to provide public
More informationThis summary outlines the burden of targeted diseases and program implementation outcomes in Nigeria. AFRICAN REGION
ia The control of neglected tropical diseases represents a major challenge to those providing healthcare services in the endemic countries. The purpose of this country profile is to provide public health
More informationPresentation by Dr Philippe Douste-Blazy. Chair of UNITAID Special Representative of the UN SG for Innovative Financing for Development
Presentation by Dr Philippe Douste-Blazy Chair of UNITAID Special Representative of the UN SG for Innovative Financing for Development The Millennium Goals : Hope for Humanity 2000 UN Millennium Summit
More informationIntestinal Parasites. James Gaensbauer MD, MScPH Fellow, Pediatric Infectious Diseases University of Colorado School of Medicine November 12, 2012
Intestinal Parasites James Gaensbauer MD, MScPH Fellow, Pediatric Infectious Diseases University of Colorado School of Medicine November 12, 2012 Outline Parasites 101 Global Burden of Disease An Evolutionary
More informationSummary World Malaria Report 2010
Summary The summarizes information received from 106 malaria-endemic countries and other partners and updates the analyses presented in the 2009 Report. It highlights continued progress made towards meeting
More informationNTDs: update on the progress. Department of Control of Neglected Tropical Diseases
NTDs: update on the progress Department of Control of Neglected Tropical Diseases WHO Department of control of Neglected Tropical Diseases Two main groups of diseases: IDM (Innovative and Intensified Diseases
More informationUNAIDS 2016 THE AIDS EPIDEMIC CAN BE ENDED BY 2030 WITH YOUR HELP
UNAIDS 2016 THE AIDS EPIDEMIC CAN BE ENDED BY 2030 WITH YOUR HELP WHY UNAIDS NEEDS YOUR SUPPORT Over the past 35 years, HIV has changed the course of history. The massive global impact of AIDS in terms
More informationThe Western Pacific Region faces significant
COMBATING COMMUNICABLE DISEASES A medical technician draws blood for HIV screening in Manila. AFP elimination of mother-to-child transmission of HIV and congenital syphilis was piloted in Malaysia and
More informationFact sheet. Poliomyelitis. WHO Media centre. ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM
Fact sheet Poliomyelitis WHO Media centre ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM Media centre Poliomyelitis Fact sheet Updated April 2016 Key
More informationNeglected tropical diseases: an emerging public health problem in the Eastern Mediterranean Region
Regional Committee for the EM/RC54/4 Eastern Mediterranean September 2007 Fifty-fourth Session Original: Arabic Agenda item 6 (b) Technical paper Neglected tropical diseases: an emerging public health
More informationA NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA
A NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA The Global Financing Facility in Support of Every Woman Every Child Photo by Maria Fleischmann WHY NOW? Photo by Dominic Chavez Countries have
More informationOkinawa, Toyako, and Beyond: Progress on Health and Development
Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,
More informationREGIONAL COMMITTEE FOR AFRICA AFR/RC53/13 Rev June 2003 Fifty-third session Johannesburg, South Africa, 1 5 September 2003
WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR AFRICA ORGANISATION MONDIALE DE LA SANTE BUREAU REGIONAL DE L AFRIQUE ORGANIZAÇÃO MUNDIAL DE SAÚDE ESCRITÓRIO REGIONAL AFRICANO REGIONAL COMMITTEE FOR AFRICA
More informationDRAFT. Regional Action Framework for Control and Elimination of Neglected Tropical Diseases in the Western Pacific
page 7 ANNEX DRAFT Regional Action Framework for Control and Elimination of Neglected Tropical Diseases in the Western Pacific page 8 CONTENTS Abbreviations... 9 Executive summary... 11 1. Background...
More information44th Myanmar Health Research Congress
44th Myanmar Health Research Congress Early Detection of Lymphatic Disturbance in Adolescent Infected with Lymphatic Filariasis Jan Douglass 1, Susan Gordon 1, Patricia Graves 1, Ben Dickson 1, Dr Ni Ni
More informationThe Global Fund & UNICEF Partnership
The Global Fund & UNICEF Partnership Prof Michel D. Kazatchkine Executive Director UNICEF Executive Board February 9 th, 2011 The Global Fund Millennium Development Goals 1. Eradicate extreme poverty and
More informationSTH SOIL-TRANSMITTED HELMINTHIASES ELIMINATING SOIL-TRANSMITTED HELMINTHIASES AS A PUBLIC HEALTH PROBLEM IN CHILDREN
STH SOIL-TRANSMITTED HELMINTHIASES ELIMINATING SOIL-TRANSMITTED HELMINTHIASES AS A PUBLIC HEALTH PROBLEM IN CHILDREN PROGRESS REPORT 2001 2010 AND STRATEGIC PLAN 2011 2020 STH_with_Alex_corrections_30_03.indd
More informationinnovative finance The GAVI Matching Fund A public-private partnership to save children s lives
innovative finance The GAVI Matching Fund A public-private partnership to save children s lives August 2013 The challenge Abdul, a young boy in Sierra Leone, was one of the lucky ones. He was severely
More informationWorld Health Organization. A Sustainable Health Sector
World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL
More informationVIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...
8 April 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH PROGRAMME SUBCOMMITTEE Sixty-fourth session Brazzaville, Republic of Congo, 9 11 June 2014 Provisional agenda item 6 VIRAL HEPATITIS: SITUATION
More informationin East Asia and the Pacific
Addressing HIV/AIDS in East Asia and the Pacific The World Bank East Asia and the Pacific Region blic Disclosure Authorized Public Disclosure Authorized Public Disclosure Authorized Public Disclosure Authorized
More informationVIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...
5 November 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-fourth session Cotonou, Republic of Benin, 3 7 November 2014 Provisional agenda item 11 VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES
More information